25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: Data from a large international inception cohort

Arthritis Care and Research

Volumn 66, Issue 8, 2014, Pages 1167-1176

  Lertratanakul, Apinya ^a   Wu, Peggy ^a   Dyer, Alan ^a   Urowitz, Murray ^b   Gladman, Dafna ^b   Fortin, Paul ^b,c,w   Bae, Sang Cheol ^d   Gordon, Caroline ^e   Clarke, Ann ^f   Bernatsky, Sasha ^f   Hanly, John G ^g   Isenberg, David ^h   Rahman, Anisur ^h   Merrill, Joan ⁱ   Wallace, Daniel J ^j   Ginzler, Ellen ^k   Khamashta, Munther ^l   Bruce, Ian ^m   Nived, Ola ⁿ   Sturfelt, Gunnar ⁿ   Steinsson, Kristjan ^o   Manzi, Susan ^p   Dooley, Mary Anne ^q   Kalunian, Kenneth ^r   Petri, Michelle ^s   Aranow, Cynthia ^t   Font, Josep ^x   Van Vollenhoven, Ronald ^u   Stoll, Thomas ^v   Ramsey Goldman, Rosalind ^a   more..

^a NORTHWESTERN UNIVERSITY   (United States)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d Hanyang Institute of Bioscience and Biotechnology   (South Korea)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f MCGILL UNIVERSITY   (Canada)

^g DALHOUSIE UNIVERSITY   (Canada)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k SUNY DOWNSTATE MEDICAL CENTER   (United States)

^l ST THOMAS HOSPITAL   (United Kingdom)

^m UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁿ LUND UNIVERSITY HOSPITAL   (Sweden)

^o LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^p ALLEGHENY GENERAL HOSPITAL   (United States)

^q UNIVERSITY OF NORTH CAROLINA   (United States)

^r UNIVERSITY OF SAN DIEGO   (United States)

^s JOHNS HOPKINS UNIVERSITY   (United States)

^t Feinstein Institute of Medical Research   (United States)

^u KAROLINSKA INSTITUTE   (Sweden)

^v KANTONSSPITAL   (Switzerland)

^w Université Laval   (Canada)

^x NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOUBLE STRANDED DNA; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUPUS ANTICOAGULANT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALARIA; MALE; RISK FACTOR; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84905046025     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22291     Document Type: Article

References (50)

1. Giovannucci E, Liu Y, Hollis BW, Rimm EB,. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008; 168: 1174-80.
2. Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ,. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 2008; 102: 1540-4.
3. Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C, Reeve J, et al. Reduced vitamin D in acute stroke. Stroke 2006; 37: 243-5.
4. Kendrick J, Targher G, Smits G, Chonchol M,. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009; 205: 255-60.
5. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167: 1159-65.
6. Hypponen E, Berry D, Cortina-Borja M, Power C,. 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort. PLoS One 2010; 5: e10801.
7. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408-15.
8. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA,. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976; 60: 221-5.
9. Urowitz MB, Gladman D, Ibanez D, Fortin P, Sanchez-Guerrero J, Bae S, et al, and the Systemic Lupus International Collaborating Clinics. Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum 2008; 59: 176-80.
10. Urowitz MB, Gladman DD,. Atherosclerosis and lupus: the SLICC Study. Lupus 2007; 16: 925-8.
11. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2331-7.
12. Bruce IN, Gladman DD, Urowitz M,. Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am 2000; 26: 257-78.
13. Adorini L, Penna G,. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008; 4: 404-12.
14. Huisman AM, White KP, Algra A, Harth M, Vieth R, Jacobs JW, et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 2001; 28: 2535-9.
15. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS,. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006; 5: 114-7.
16. Becker A, Fischer R, Schneider M,. Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Z Rheumatol 2001; 60: 352-8. In German.
17. Kamen D, Aranow C,. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 2008; 20: 532-7.
18. Wright TB, Shults J, Leonard MB, Zemel BS, Burnham JM,. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 2009; 155: 260-5.
19. Lemire JM, Ince A, Takashima M,. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 1992; 12: 143-8.
20. Abe J, Nakamura K, Takita Y, Nakano T, Irie H, Nishii Y,. Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 α,25-dihydroxyvitamin D3. J Nutr Sci Vitaminol (Tokyo) 1990; 36: 21-31.
21. Wu PW, Rhew EY, Dyer AR, Dunlop DD, Langman CB, Price H, et al. 25-Hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum 2009; 61: 1387-95.
22. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
23. Gladman DD, Ibanez D, Urowitz MB,. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002; 29: 288-91.
24. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-9.
25. Urowitz MB, Gladman D, Ibanez D, Bae SC, Sanchez-Guerrero J, Gordon C, et al, for the Systemic Lupus International Collaborating Clinics. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010; 62: 881-7.
26. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR,. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002; 30: 771-7.
27. Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C,. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 2008; 47: 920-3.
28. Amital H, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010; 69: 1155-7.
29. Toloza SM, Cole DE, Gladman DD, Ibanez D, Urowitz MB,. Vitamin D insufficiency in a large female SLE cohort. Lupus 2010; 19: 13-9.
30. Bonakdar ZS, Jahanshahifar L, Jahanshahifar F, Gholamrezaei A,. Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus 2011; 20: 1155-60.
31. Reynolds JA, Haque S, Berry JL, Pemberton P, Teh LS, Ho P, et al. 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2012; 51: 544-51.
32. Sumethkul K, Boonyaratavej S, Kitumnuaypong T, Angthararuk S, Cheewasat P, Manadee N, et al. The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus. Rheumatol Int 2013; 33: 1461-7.
33. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106: 963-8.
34. Akin F, Ayca B, Kose N, Duran M, Sari M, Uysal OK, et al. Serum vitamin D levels are independently associated with severity of coronary artery disease. J Investig Med 2012; 60: 869-73.
35. Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO, et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta 2010; 411: 1354-60.
36. Li YC, Kong J, Wei M, Chen Z, Liu SQ, Cao L,. 1,25-Dihydroxyvitamin D 3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-38.
37. Shea MK, Booth SL, Massaro JM, Jacques PF, D'Agostino RB, Dawson-Hughes B, et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2008; 167: 313-20.
38. Amer M, Qayyum R,. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol 2012; 109: 226-30.
39. Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M,. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporosis Int 2009; 20: 427-33.
40. Abou-Raya A, Abou-Raya S, Helmii M,. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol 2013; 40: 265-72.
41. Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, Melamed ML,. Association of glucocorticoid use and low 25- hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab 2011; 96: 3838-45.
42. Akeno N, Matsunuma A, Maeda T, Kawane T, Horiuchi N,. Regulation of vitamin D-1α-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney. J Endocrinol 2000; 164: 339-48.
43. O'Leary TJ, Jones G, Yip A, Lohnes D, Cohanim M, Yendt ER,. The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis. N Engl J Med 1986; 315: 727-30.
44. De Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, Siscovick DS,. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 2009; 20: 1805-12.
45. Ravenell RL, Kamen DL, Spence JD, Hollis BW, Fleury TJ, Janech MG, et al. Hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. Am J Med Sci 2012; 344: 268-73.
46. Romero-Diaz J, Vargas-Vorackova F, Kimura-Hayama E, Cortazar-Benitez LF, Gijon-Mitre R, Criales S, et al. Systemic lupus erythematosus risk factors for coronary artery calcifications. Rheumatology (Oxford) 2012; 51: 110-9.
47. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2399-406.
48. Petri M, Bello KJ, Fang H, Magder LS,. Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum 2013; 65: 1865-71.
49. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007; 115: 846-54.
50. Manson JE, Allison MA, Carr JJ, Langer RD, Cochrane BB, Hendrix SL, et al. Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative. Menopause 2010; 17: 683-91.